Compare CAI & NXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CAI | NXE |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 6.2B |
| IPO Year | 2025 | N/A |
| Metric | CAI | NXE |
|---|---|---|
| Price | $26.54 | $8.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $34.43 | N/A |
| AVG Volume (30 Days) | 2.5M | ★ 7.4M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $649,062,000.00 | N/A |
| Revenue This Year | $77.69 | N/A |
| Revenue Next Year | $35.80 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 112.02 | N/A |
| 52 Week Low | $22.86 | $3.91 |
| 52 Week High | $42.50 | $9.99 |
| Indicator | CAI | NXE |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 46.45 |
| Support Level | N/A | $8.95 |
| Resistance Level | N/A | $9.60 |
| Average True Range (ATR) | 0.00 | 0.46 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 0.00 | 35.07 |
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
NexGen Energy Ltd is an exploration and development entity engaged in acquiring, evaluating, and developing uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin.